ARS Pharmaceuticals
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
About ARS Pharmaceuticals
ARS Pharmaceuticals is a stealth pharmaceutical company that developed a novel intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient, and more reliable for patients and loved ones at risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis.
Company Facts
- Headquarters
- San Diego
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $175,000,000
- Last Funding Type
- post_ipo_debt
- Last Funding Date
- 2025-09-29
- Website
- ars-pharma.com
Industries & Categories
Biopharma, Health Care, Medical, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/ars-pharmaceuticals-16576 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.